Related Experiment Videos
Effect of different cytostatic protocols on oncogene expression in CBA/Ca mice
1Department of Public Health, University Medical School of Pécs, Hungary.
Anticancer Research
|July 1, 1995
Summary
Investigating cancer-causing chemicals requires understanding oncogene action. This study found that cytostatic drug protocols, particularly those with cyclophosphamide, altered early oncogene expression in mice.
Area of Science:
- Toxicology
- Oncogene research
- Carcinogenesis
Background:
- In vivo studies of oncogene action are crucial for understanding potential carcinogen toxicology.
- Early oncogene expression changes can indicate toxic effects of chemical agents.
Purpose of the Study:
- To investigate the early effects of various cytostatic drug protocols on oncogene expression.
- To identify specific oncogenes affected by these treatments in a mouse model.
Main Methods:
- CBA/Ca mice were subjected to different cytostatic protocols.
- Early oncogene expression levels were monitored post-treatment.
Main Results:
- Most tested cytostatic protocols induced detectable early changes in oncogene expression.
- Protocols containing cyclophosphamide showed significant effects.
- N-ras, c-myc, and c-myb were the most frequently altered oncogenes.
Conclusions:
- Cytostatic agents can rapidly influence oncogene expression in vivo.
- Cyclophosphamide-containing regimens are particularly potent in altering early oncogene activity.
- Findings contribute to understanding the toxicological mechanisms of cytostatic drugs.